| Bioactivity | ASGITFSNSGMHW(Val-13C5,15N)R TFA is an isotope of ASGITFSNSGMHWVR TFA labeled with 13C and 15N[1]. |
| Sequence | Ala-Ser-Gly-Ile-Thr-Phe-Ser-Asn-Ser-Gly-Met-His-Trp-(Val-13C5,15N)-Arg |
| Shortening | ASGITFSNSGMHW(Val-13C5,15N)R |
| Formula | C6713C5H108N2115NO21S.xC2HF3O2 |
| Molar Mass | 1655.78 (free acid) |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Russak E M, et al. Impact of deuterium substitution on the pharmacokinetics of pharmaceuticals[J]. Annals of Pharmacotherapy, 2019, 53(2): 211-216. |
ASGITFSNSGMHW(Val-13C5,15N)R TFA
CAS: F: C6713C5H108N2115NO21S.xC2HF3O2 W: 1655.78 (free acid)
ASGITFSNSGMHW(Val-13C5,15N)R TFA is an isotope of ASGITFSNSGMHWVR TFA labeled with13C and 15N.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.